April 13, 2023 | 5 min read

Navigating Conversations About Psychedelics With Patients

By Natalie Gukasyan, MD, Johns Hopkins Medicine

There’s been growing interest in the therapeutic potential of psychedelics. This requires that healthcare professionals be well informed and prepared to discuss this experimental therapy.

September 13, 2022 | 2 min read

Psychedelics and Health

By Mary Yaden, MD, Johns Hopkins Medicine

Psychedelic therapies have long been feared and avoided. We must acknowledge that there are clinical indications where these treatments are profoundly beneficial.   

November 2, 2022 | 2 min read

Psychedelics to Quit Smoking?

By Matthew Johnson, PhD, Johns Hopkins Medicine

Patients may ask about using psilocybin to stop smoking. While being actively studied, please remind them that it’s still illegal and not necessarily risk-free. 

April 14, 2022 | 3 min read

Equity and Ethical Considerations With The Use of Psychedelics

By Ian Pocock, LICSW, Washington

Psychedelic medicines may help patients suffering with PTSD and treatment-resistant depression. As with many new therapies, ethical considerations and ensuring equal access for everyone are works in progress.